THU0646 HIGH LEVELS OF DAMAGE IN INFLAMMATORY RHEUMATIC DISEASES: A CLUE TO LOW RATES OF REMISSION AND LOW DISEASE ACTIVITY

Background

Despite introduction of powerful biologic medications over the last 2 decades, rates of remission and low disease activity rates in RA remain less than 50%. One possible basis is that measures and indices such as disease activity score 28 (DAS28) and clinical disease activity index (CDAI), while sensitive primarily to disease activity in clinical trial patients selected for high inflammatory activity, may also reflect...